Use of Mangafodipir for treating oxidative stress effects
US7351722B2 · kind B2 · utility
7Cited by
0References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 26, 2002 |
| Grant date | Apr 1, 2008 |
| Priority date | — |
| Expiry date | Oct 19, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P1/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention concerns the use of Mangafodipir to obtain a medicine for preventive or curative treatment of hepatocellular deficiencies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.